Full Text View
Tabular View
No Study Results Posted
Related Studies
Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function (ACP)
This study has been completed.
Study NCT00943059   Information provided by Maastricht University Medical Center

First Received on July 20, 2009.   Last Updated on May 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Cardiomyopathy, Dilated
Additional conditions recognized in this trial
Cardiomyopathies
Diabetes Mellitus
More general conditions related to this trial
Cardiomegaly
Cardiovascular Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Heart Diseases
Metabolic Diseases
Interventions listed in this trial
Acipimox
Cellulosum Mycrocryst
More general drug interventions related to this trial
Antimetabolites
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Maastricht University Medical Center
Center for Translational Molecular Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services